Morgan Stanley Global Endurance I holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Morgan Stanley Global Endurance Portfolio Class I MSJIX
- NAV / 1-Day Return 20.67 / −0.48 %
- Total Assets 15.2M
-
Adj. Expense Ratio
1.000%
- Expense Ratio 1.000%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Global Small/Mid Stock
- Investment Style Small Blend
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.53%
- Turnover 176%
USD | NAV as of Jun 11, 2026 | 1-Day Return as of Jun 11, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MSJIX
Will MSJIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the MSJIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of MSJIX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 51.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Roivant Sciences Ltd Ordinary Shares | 8.73 | 1M | Healthcare |
Victoria PLC | 7.88 | 1M | Consumer Cyclical |
QXO Inc | 5.36 | 833,662 | Industrials |
Teleflex Inc | 5.13 | 797,799 | Healthcare |
Immunovant Inc | 4.66 | 724,459 | Healthcare |
Calumet Inc | 4.65 | 723,636 | Basic Materials |
Arbutus Biopharma Corp | 4.28 | 666,396 | Healthcare |
Appian Corp Class A | 4.18 | 650,440 | Technology |
Floor & Decor Holdings Inc Class A | 3.76 | 585,267 | Consumer Cyclical |
Royalty Pharma PLC Class A | 3.18 | 494,235 | Healthcare |
United States